why choose us

300×250 Ad Slot

Research Article: Application of Circulating Tumor Cells and Interleukin- in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer

Date Published: 2023-07-20

Abstract:
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer death worldwide. Peritoneal metastasis is the common way of distant metastasis of gastric cancer and the main cause of poor prognosis. Previous studies have shown that the median survival time of peritoneal metastases is only – months.– Once a patient is diagnosed with peritoneal metastases, traditional gastrectomy and regional lymph node dissection will no longer be the optimal treatment options. Recent studies have shown that hyperthermic intraperitoneal chemotherapy (HIPEC) + cytoreductive surgery (CRS), conversion therapy and targeted therapy can improve the prognosis of gastric cancer patients with peritoneal metastasis, and even some patients with early peritoneal metastasis have the opportunity of surgical resection after comprehensive treatment. Therefore, early and accurate diagnosis of peritoneal metastases is essential to formulate the optimal treatment plan and avoid unnecessary surgery.–

Introduction:
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer death worldwide. Peritoneal metastasis is the common way of distant metastasis of gastric cancer and the main cause of poor prognosis. Previous studies have shown that the median survival time of peritoneal metastases is only – months. – Once a patient is diagnosed with peritoneal metastases, traditional gastrectomy and regional lymph node dissection will no longer be the optimal treatment options. Recent studies have shown…

Read more

300×250 Ad Slot